Methods : 28-day mortality and other clinical outcomes in a randomized controlled trial of Dexamethasone (DEX) among hospitalized COVID-19 patients in the UK RECOVERY project
- About the RECOVERY trial
- Study design
- Sample size and ending enrollment
- Statistical analysis
0
1
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Learn After
Study design for evaluating 28-day mortality and other clinical outcomes in a randomized controlled trial of Dexamethasone (DEX) among hospitalized COVID-19 patients in RECOVERY trial
Sample size and ending enrollment in evaluating 28-day mortality and other clinical outcomes in a randomized controlled trial of Dexamethasone (DEX) among hospitalized COVID-19 patients in RECOVERY trial
Statistical analysis for evaluating 28-day mortality and other clinical outcomes in a randomized controlled trial of Dexamethasone (DEX) among hospitalized COVID-19 patients in RECOVERY trial
RECOVERY trial: a system for evaluating COVID-19 treatments